Delivery Order SPE2DR25D2205-SPE2DR26F1S83
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,334.12 on August 13, 2025, for Flarex 0.1% eye drops (5mL). This competitive award, which is not set-aside and features firm fixed-price pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $4,510.23 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on July 23, 2025, with completion expected by July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Flarex 0.1% eye drops in a 5ML formulation, valued at $6,379.24. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger pharmaceutical supply agreement. The order is expected to be completed by August 21, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,527.72 to AmerisourceBergen Drug Corp for FLAREX 0.1% eye drops (5 mL) on December 30, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $4,715.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on November 7, 2025, with an ultimate completion date of November 10, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order will be...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,375.32, is for the delivery of FLAREX 0.1% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 21, 2023. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $346,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562093840 FLAREX 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliter bottles of the eye drops to meet requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 8 to September 11, 2023. No major subcontractors or set aside designations were...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops in 5 milliliter vials. The contract has a firm fixed price of $4,650.00 and a completion date of August 30, 2024. No set-aside was used for this award. AmerisourceBergen, through its corporate office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,356.51 firm fixed price delivery order is for the supply of FLAREX 0.1% eye drops, a specialty ophthalmic medication. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this order as well as other indefinite delivery contracts (IDCs) by the DLA and Department...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product. The contract has a ceiling value of $7,347.51 and a period of performance that extends to July 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1S83Delivery Order
The Defense Logistics Agency awarded a $6,821.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Flarex 0.1% ophthalmic drops (5mL), with an ultimate completion date of January 6, 2026. This non-set-aside competitive award was issued on January 5, 2026, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion potential value through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of competitively awarded federal contracts covering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This specific delivery order for ocular pharmaceutical products aligns with AmerisourceBergen's established capability to supply specialty medications and brand-name drugs across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/4/26 |